Peter Schulz-knappe
Oncology
Protagen AG
Germany
Biography
Peter Schulz-Knappe is working as MD and Cell Biologist by training. He is a Board Member of biotech companies and serves as CSO since 1997. His scientific passion for the last 25 years has been in the discovery, validation and development of protein biomarkers from blood. His main research topics are: proteomics, peptidomics, biomarkers, autoantibodies, protein microarrays, IVD-development. He has published and co-authored over 100 peer reviewed papers. In addition, he is inventor of > 20 patents and patent families on peptides, biomarkers, and analytical procedures. Peter Schulz-Knappe is working as MD and Cell Biologist by training. He is a Board Member of biotech companies and serves as CSO since 1997. His scientific passion for the last 25 years has been in the discovery, validation and development of protein biomarkers from blood. His main research topics are: proteomics, peptidomics, biomarkers, autoantibodies, protein microarrays, IVD-development. He has published and co-authored over 100 peer reviewed papers. In addition, he is inventor of > 20 patents and patent families on peptides, biomarkers, and analytical procedures.
Research Interest
Cancer Studies Cancer prevention Oncology
